Tag: FDA MedWatch

How to Report Adverse Drug Reactions to FDA MedWatch

How to Report Adverse Drug Reactions to FDA MedWatch

Learn how to report adverse drug reactions to the FDA's MedWatch program. Understand what counts as reportable, how to fill out the form, and why your report matters for drug safety.

Recent Posts

How and Where to Buy Aldactone Online: A Safe Guide for 2026
May, 14 2026
How and Where to Buy Aldactone Online: A Safe Guide for 2026

Learn how to safely buy Aldactone (spironolactone) online in 2026. Compare prices from Nurx, GoodRx, and Blink Health, and discover how to avoid illegal pharmacies.

Gabapentinoids in Pregnancy: What the Latest Safety Data Shows
Jan, 5 2026
Gabapentinoids in Pregnancy: What the Latest Safety Data Shows

Current evidence shows gabapentin and pregabalin may increase risks of preterm birth, heart defects, and neonatal withdrawal in pregnancy. Safer alternatives exist, and careful monitoring is essential if these drugs are used.

Nexium (Esomeprazole) vs Alternatives: What Works Best for Acid Reflux?
Nov, 18 2025
Nexium (Esomeprazole) vs Alternatives: What Works Best for Acid Reflux?

Compare Nexium (esomeprazole) with generic alternatives like omeprazole, lansoprazole, and pantoprazole. Learn which PPI works best for acid reflux, how to switch safely, and when lifestyle changes can replace medication.

Glucovance vs Alternatives: Detailed Comparison for Type 2 Diabetes
Oct, 10 2025
Glucovance vs Alternatives: Detailed Comparison for Type 2 Diabetes

A side‑by‑side look at Glucovance versus Metformin alone, sulfonylureas, DPP‑4, SGLT2 and GLP‑1 drugs, covering efficacy, safety, cost and when to switch.

180-Day Exclusivity: How Patent Challenges Delay Generic Drug Entry
Dec, 3 2025
180-Day Exclusivity: How Patent Challenges Delay Generic Drug Entry

The 180-day exclusivity rule under the Hatch-Waxman Act was meant to speed up generic drug entry-but now it often delays it. Learn how patent challenges, FDA rules, and corporate strategy keep prices high and patients waiting.